← Back to Search

Other

MedSafer-supplemented medication reconciliation for Kidney Failure (MedSafer-HD Trial)

N/A
Waitlist Available
Led By Emily McDonald, MD MSc
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
On one of the study units
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

MedSafer-HD Trial Summary

This trial is testing an electronic tool to reduce medication overload for dialysis patients, which could lower the burden of taking multiple medications.

Eligible Conditions
  • Kidney Failure
  • Type 2 Diabetes
  • Anemia
  • Medication Interaction
  • Chronic Kidney Disease
  • High Blood Pressure

MedSafer-HD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are already enrolled in the study.

MedSafer-HD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients with one or more PIMs deprescribed
Secondary outcome measures
Mean number of total medications

MedSafer-HD Trial Design

2Treatment groups
Active Control
Group I: MedSafer-supplemented medication reconciliationActive Control1 Intervention
This unit will act as an intervention unit for the MedRec where MedSafer deprescribing reports will be handed to the treating team and deprescribing brochures from the Canadian Deprescribing Network will be given to patients.
Group II: Standard of care medication reconciliationActive Control1 Intervention
This unit will serve as the control unit where standard of care will be provided and no deprescribing reports nor brochures will be delivered. MedSafer reports will be generated but withheld from the clinical team. This will serve as a comparator to determine if the intervention unit was more successful in deprescribing compared to this control unit.

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
440 Previous Clinical Trials
158,821 Total Patients Enrolled
Emily McDonald, MD MScPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for participation in this research project?

"As indicated on clinicaltrials.gov, the trial posted on October 3rd 2022 is no longer searching for participants. However, there are still 1973 other studies that currently require patient recruitment."

Answered by AI
~81 spots leftby Mar 2025